| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |